Dr. Mijung Lee, MD
- Medicare services, 2024
- 1,742
- Medicare patients, 2024
- 431
- Part D claims, 2024
- 764
- Publications
- 6
- Clinical trials
- 10
- Practice address
- 525 Lilly Rd NE, Olympia, WA 98506
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Providence Medical Group Olympia Cardiac Surgery - HOPD
Acute Care Hospital outpatient department · Olympia, Washington
Find Dr. Lee's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Mijung Lee is a medical oncologist in Olympia, Washington
Dr. Lee practices at Providence Medical Group Olympia Cardiac Surgery - HOPD in Olympia, Washington.
Dr. Lee's NPI, 1093970048, was assigned on July 18, 2008. Dr. Lee holds Washington license MD61251868.
- NPI
- 1093970048NPI Registry (opens in a new tab)
- Medicare PAC ID
- 5991921751
- NPI enumeration date
- July 18, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 44
- Medical school graduation
- 2008
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Mijung Lee practices at Providence Medical Group Olympia Cardiac Surgery - HOPD in Olympia, Washington
Dr. Lee's primary practice is Providence Medical Group Olympia Cardiac Surgery - HOPD, at 525 Lilly Rd NE, Olympia, WA 98506.
- Providence Medical Group Olympia Cardiac Surgery - HOPD525 Lilly Rd NE, Olympia, WA 98506
Source: Dmand AI Affiliation Data
Dr. Mijung Lee is affiliated with 9 sites of care and 3 medical groups
Dr. Lee's primary practice is Providence Medical Group Olympia Cardiac Surgery - HOPD in Olympia, Washington. Dr. Lee is also affiliated with Providence St. Peter Hospital. The medical group on file is Providence Medical Group - South Puget Sound (Olympia). Dmand AI also links Dr. Lee to 4 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account. Dr. Lee's employer is on file too: a hospital.
Source: Dmand AI Affiliation Data
Dmand AI tracks the EHR system at Dr. Mijung Lee's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 9 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Providence Medical Group Olympia Cardiac Surgery - HOPD | Available with a free account |
| +8 more sites and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Mijung Lee is one of 145 medical oncologists in Washington
Medical oncology is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lee is board certified in hematology by the American Board of Internal Medicine. Dr. Lee is licensed in Washington.
Specialties and state licenses
- Medical oncology, WashingtonPrimary
Medical oncologists near Dr. Lee
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Mijung Lee billed Medicare for 1,742 services in 2024
CMS data shows 1,742 Medicare services from Dr. Lee across 9 procedure codes in 2024, for 431 Medicare patients. Medicare paid $119,257 for them.
Dr. Lee's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 1,2912024: 1,14212%
- Other services
- 2023: 02024: 600
Where Dr. Lee's Medicare services took place, 2024
- In an office1,69397%
- In a facility493%
Dr. Lee compared with the Washington median for medical oncologists, 2024
- Dr. Lee
- Washington median
- Medicare services
- 1,742vs 3624.8 times
- Medicare patients
- 431vs 1393.1 times
- Part D claims
- 547vs 1803.0 times
Medians across 131 medical oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Lee's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Lee?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Lee and other medical oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Mijung Lee treated 431 Medicare patients in 2024, average age 76
CMS counts 431 Medicare patients who saw Dr. Lee in 2024. The largest group is 75 to 84, with 191 patients. 73% of them have high blood pressure, and 63% have cancer. 9% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 74, with 68% women.
Dr. Lee's Medicare patients by age, 2024
Dr. Lee's Medicare patients by sex, 2024
- Women28666%
- Men14534%
Chronic conditions among Dr. Lee's Medicare patients, 2024
- High blood pressure73%
- Cancer63%
- High cholesterol62%
- Arthritis40%
- Chronic kidney disease28%
- Diabetes28%
- Ischemic heart disease22%
- Mood disorders22%
Share of Medicare patients with each condition. A patient can have several.
Dr. Lee's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women68%
- Men31%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Mijung Lee wrote 764 Medicare Part D claims in 2024
In 2024, Dr. Lee wrote 764 Medicare Part D claims for 161 patients. 86% of them were for generic drugs. CMS names the drug for 547 of them, across 17 drugs with 11 or more claims each, at $628,056 in total drug cost. In 2023, CMS named 453 claims across 19 drugs.
Dr. Lee's Part D claims by kind of drug, 2024
- Generic655 claims86%
- Brand-name109 claims14%
Dr. Lee's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Lee's Part D claims, 2024
- Opioids2%15 of 764 claims
- Antibiotics2%13 of 764 claims
- Antipsychotics, patients 65 and over3%22 of 764 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 4532024: 54721%
Drugs named by CMS: 17 in 2024, 19 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Mijung Lee offers telehealth to Medicare patients
Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Mijung Lee has 6 publications on record
Dmand AI links 6 papers to Dr. Lee, published from 2017 to 2022. 2017 was the busiest year, with 2. Dr. Lee's most frequent co-authors are Paul D. Aridgides, MD, Gary A. Eastwick, MD and Ramsay S. Farah, MD.
Dr. Lee's papers by year, 2017 to 2022
Dr. Lee's most frequent co-authors
- Paul D. Aridgides, MD1 shared paper
- Gary A. Eastwick, MD1 shared paper
- Ramsay S. Farah, MD1 shared paper
Recent publications by Dr. Lee
Dementia (London)
Proc (Bayl Univ Med Cent)
See who Dr. Lee researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lee works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Mijung Lee has worked on 10 clinical trials
Dmand AI links Dr. Lee to 10 clinical trials, 5 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Breast Neoplasms, Brain Neoplasms and Glioblastoma. Alliance for Clinical Trials in Oncology sponsors the most, 4.
Clinical trials with Dr. Lee by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 2Phase 2/3: 2 trials
- 5Phase 3: 5 trials
- NonePhase 4: no trials
Trials with no phase (devices, behavioral studies) are left out.
Conditions in Dr. Lee's trials
- Breast Neoplasms
- Brain Neoplasms
- Glioblastoma
- Gliosarcoma
- Triple Negative Breast Neoplasms
Investigators on the most trials with Dr. Lee
- Brian T. Pruitt, MD4 shared trials
- Frank J. Brescia, MD3 shared trials
- Michael K. Cohenuram, MD3 shared trials
Recent clinical trials with Dr. Lee
A Phase II/III Randomized Trial of Veliparib or Placebo in Combination With Adjuvant Temozolomide in Newly Diagnosed Glioblastoma With MGMT Promoter Hypermethylation (opens in a new tab)
Optimizing Endocrine Therapy Through Motivational Interviewing and Text Interventions (opens in a new tab)
A Study Evaluating the Pregnancy Outcomes and Safety of Interrupting Endocrine Therapy for Young Women With Endocrine Responsive Breast Cancer Who Desire Pregnancy (opens in a new tab)
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Mijung Lee received $411 in industry payments from 2018 to 2025
CMS Open Payments shows 9 general payments to Dr. Lee from 5 drug and device companies from 2018 to 2025. Education make up the largest share, 62% of the total. Pfizer Inc. paid the most, $152.
General payments to Dr. Lee by program year, 2018 to 2025
General payments to Dr. Lee by kind, 2018 to 2025
- Education$25462%
- Food and beverage$15638%
Companies that paid Dr. Lee the most, 2018 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Mijung Lee is board certified in hematology
- Board certified in hematology
- Board certified in internal medicine
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Sources for Dr. Mijung Lee's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Mijung Lee
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Mijung Lee's NPI number?
Dr. Mijung Lee's NPI number is 1093970048. It was assigned on July 18, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Mijung Lee?
Dr. Mijung Lee is a medical oncologist in Olympia, Washington. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Mijung Lee practice?
Dr. Lee practices at 525 Lilly Rd NE, Olympia, WA 98506. Dr. Lee's primary practice is Providence Medical Group Olympia Cardiac Surgery - HOPD in Olympia, Washington. Dmand AI also links Dr. Lee to 4 hospitals, 3 group practices and clinics and 2 medical groups.
What is Dr. Mijung Lee's medical license number?
Dr. Lee holds Washington license MD61251868.
Which hospitals is Dr. Mijung Lee affiliated with?
Dr. Lee is affiliated with Providence St. Peter Hospital. Dmand AI links Dr. Lee to 4 more hospitals.
What medical group is Dr. Mijung Lee part of?
Dr. Lee is linked to Providence Medical Group - South Puget Sound (Olympia). Dmand AI links Dr. Lee to 2 more medical groups.
Does Dr. Mijung Lee accept Medicare?
Yes. CMS data shows Dr. Lee billed Medicare for 1,742 services in 2024, and Dr. Lee accepts Medicare assignment.
Does Dr. Mijung Lee offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Lee as offering telehealth services.
How many Medicare patients does Dr. Mijung Lee see?
CMS counts 431 Medicare patients who saw Dr. Lee in 2024, with an average age of 76.
Is Dr. Mijung Lee board certified?
Yes. Dr. Lee is board certified in hematology by the American Board of Internal Medicine.
Show 6 more questionsShow fewer questions
What services does Dr. Mijung Lee bill to Medicare?
In 2024, Dr. Lee's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, established patient (99215).
What drugs does Dr. Mijung Lee prescribe most?
In 2024 Medicare Part D data, Dr. Lee's most prescribed drugs by claims were Dexamethasone, Letrozole and Anastrozole.
Has Dr. Mijung Lee received payments from drug or device companies?
CMS Open Payments shows $411 in general payments to Dr. Lee from 5 companies from 2018 to 2025. The largest total came from Pfizer Inc.
How long has Dr. Mijung Lee been practicing?
Dr. Lee graduated from medical school in 2008, 18 years ago.
Does Dr. Mijung Lee do research?
Dmand AI links 6 publications to Dr. Lee, published from 2017 to 2022. Dr. Lee has worked on 10 clinical trials.
Who does Dr. Mijung Lee publish with?
Dr. Lee's most frequent co-authors are Paul D. Aridgides, MD (1 shared paper), Gary A. Eastwick, MD (1 shared paper) and Ramsay S. Farah, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card